日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights

在复发性子宫内膜癌和卵巢癌患者中应用Copanlisib和Niraparib联合治疗(COPANIRA):疗效、毒性和转化研究进展

Brodsky, Allison L; Asare, Amma; Fellman, Bryan; Anderson, Kristin; Yao, Jun; Lee, Sanghoon; Tran, Hai; Xu, Xun; Liu, Jinsong; Celestino, Joseph; Hajek, Richard A; Morgan, Margaret B; Mohammad, Mohammad; Soliman, Pamela; Shafer, Aaron; Sood, Anil K; Bodurka, Diane; Fleming, Nicole D; Onstad Grinsfelder, Michaela; Milojevic, Ljiljana; Jazaeri, Amir A; Mills, Gordon B; Coleman, Robert L; Westin, Shannon N

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

GOG281/LOGS 研究的分子谱分析和肿瘤生物标志物分析:曲美替尼治疗复发/持续性低级别浆液性卵巢癌的阳性后期试验

Hollis, Robert L; Miller, Austin; Lankes, Heather A; Wong, Kwong-Kwok; Rodgers, William; Millan, David; Carty, Karen; Coleman, Robert L; Moore, Kathleen N; Alvarez Secord, Angeles; O'Malley, David M; Chan, John K; Hagemann, Andrea R; Gaillard, Stephanie; Guntupalli, Saketh R; Edelson, Mitchell I; Rose, Peter G; Dorigo, Oliver; Banerjee, Susana; Ewing, Ailith; Churchman, Michael; Sood, Anil K; Herrington, C Simon; Gourley, Charlie; Gershenson, David M

Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden-High Ovarian Cancer

Gemogenovatucel-T 在克隆性肿瘤突变负荷高卵巢癌中的优势

Coleman, Robert L; Rocconi, Rodney; Monk, Bradley J; Walter, Adam; Stanbery, Laura; Willoughby, David; Nagel, Casey; Wei, Qi; Wallraven, Gladice; Horvath, Staci; Tang, Min; Rao, Donald; Bognar, Ernest; Nemunaitis, John

The GOG Foundation and EVA/LACOG partnership: a collaborative strategic alliance for clinical trial execution

GOG基金会与EVA/LACOG的合作:临床试验执行方面的战略联盟

Maluf, Fernando; Coleman, Robert L; Nogueira-Rodrigues, Angélica; Monk, Bradley J; Baiocchi, Glauco; Moore, Kathleen N; de Melo, Andréia Cristina; O'Malley, David M; Dal Molin, Graziela Z; Randall, Leslie M; Giornelli, Gonzalo; Slomovitz, Brian; Pareja, René; Pothuri, Bhavana; Eskander, Ramez N; Werutsky, Gustavo; Herzog, Thomas J

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial

Rucaparib用于铂敏感复发性卵巢癌维持治疗:3期随机、安慰剂对照ARIEL3试验的最终结果

Ledermann, Jonathan A; Oza, Amit M; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I; Clamp, Andrew R; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W; Gancedo, Margarita Amenedo; Fong, Peter C; Goh, Jeffrey C; O'Malley, David M; Armstrong, Deborah K; Banerjee, Susana; García-Donas, Jesús; Swisher, Elizabeth M; Lebreton, Coriolan; Konecny, Gottfried E; McNeish, Iain A; Scott, Clare L; Maloney, Lara; Goble, Sandra; Lin, Kevin K; Coleman, Robert L

A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel

一份用通俗易懂的语言总结了接受多斯他利单抗联合卡铂-紫杉醇治疗的子宫内膜癌患者的生存情况的报告。

Powell, Matthew A; Bjørge, Line; Willmott, Lyndsay; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Gropp-Meier, Martina; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Segev, Yakir; Gill, Sarah E; Gennigens, Christine; Sebastianelli, Alexandra; Shahin, Mark S; Pothuri, Bhavana; Monk, Bradley J; Buscema, Joseph; Coleman, Robert L; Slomovitz, Brian M; Ring, Kari L; Herzog, Thomas J; Balas, Morad Marco; Grimshaw, Matthew; Stevens, Shadi; Lai, Dominic W; McCourt, Carolyn; Mirza, Mansoor Raza

Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression

贝伐单抗在疾病进展后的治疗:卵巢癌、输卵管癌和腹膜癌患者在疾病进展后再次接受贝伐单抗治疗的影响

Asare, Amma; Previs, Rebecca Ann; Spinosa, Daniel; Fellman, Bryan; Scott, Amelia L; Mulder, Isabelle; Mahmoud, May; Enbaya, Ahmed; Siedel, Jean Hansen; Cobb, Lauren; Soliman, Pamela T; Sood, Anil K; Coleman, Robert L; Secord, Angeles Alvarez; Westin, Shannon N

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

“多斯利单抗治疗原发性晚期或复发性子宫内膜癌”的简明语言摘要

Mirza, Mansoor R; Chase, Dana M; Slomovitz, Brian M; Christensen, René dePont; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Hanker, Lars C; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Auranen, Annika; Pothuri, Bhavana; Cibula, David; McCourt, Carolyn; Raspagliesi, Francesco; Shahin, Mark S; Gill, Sarah E; Monk, Bradley J; Buscema, Joseph; Herzog, Thomas J; Copeland, Larry J; Tian, Min; He, Zangdong; Stevens, Shadi; Zografos, Eleftherios; Coleman, Robert L; Powell, Matthew A

Pathways linking benefit finding, fear of cancer recurrence, and family support to fertility concerns in women of reproductive age with malignant tumors: a cross-sectional study

一项横断面研究探讨了在患有恶性肿瘤的育龄女性中,获益寻求、癌症复发恐惧和家庭支持与生育问题之间的关联路径:一项横断面研究

He, Xinying; Han, Xue; Zeng, Lihua; Chen, Qin; Ye, Min; Fan, Xuemei; Xu, Pengfei; Finelli, Renata; Moisidis-Tesch, Christina M; Coleman, Robert L; Ji, Chenbo; Qiao, Chengping

ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design

ENGOT-EN20/GOG-3083/XPORT-EC-042——一项III期、随机、安慰剂对照、双盲、多中心试验,评估塞利尼索在p53野生型、晚期或复发性子宫内膜癌患者系统治疗后维持治疗中的疗效:研究原理、方法和试验设计

Vergote, Ignace; Perez Fidalgo, Alejandro; Valabrega, Giorgio; Monk, Bradley J; Herzog, Thomas; Cibula, David; Colombo, Nicoletta; Pothuri, Bhavana; Sehouli, Jalid; Korach, Jacob; Barlin, Joyce; Papadimitriou, Christos A; van Gorp, Toon; Richardson, Debra; McCarthy, Michael; Antill, Yoland; Mirza, Mansoor Raza; Li, Kai; Kalyanapu, Pratheek; Slomovitz, Brian; Coleman, Robert L